狠狠撸shows by User: JinDi2
/
http://www.slideshare.net/images/logo.gif狠狠撸shows by User: JinDi2
/
Tue, 28 Feb 2017 06:39:18 GMT狠狠撸Share feed for 狠狠撸shows by User: JinDi2LakePharma General Technical Overview
/slideshow/lakepharma-general-technical-overview/72650266
2016-12-20-lakepharma-general-technical-overview-170228063918 LakePharma General Technical Overview]]>
LakePharma General Technical Overview]]>
Tue, 28 Feb 2017 06:39:18 GMT/slideshow/lakepharma-general-technical-overview/72650266JinDi2@slideshare.net(JinDi2)LakePharma General Technical OverviewJinDi2LakePharma General Technical Overview<img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/2016-12-20-lakepharma-general-technical-overview-170228063918-thumbnail.jpg?width=120&height=120&fit=bounds" /><br> LakePharma General Technical Overview
]]>
961https://cdn.slidesharecdn.com/ss_thumbnails/2016-10-24-protein-manufacturing-utilizing-a-titerless-baculovirus-platform-170228063744-thumbnail.jpg?width=120&height=120&fit=boundsdocumentBlackhttp://activitystrea.ms/schema/1.0/posthttp://activitystrea.ms/schema/1.0/posted0Multi-domain Challenges of Fc Fusion Proteins and Bispecific Antibodies
/slideshow/multidomain-challenges-of-fc-fusion-proteins-and-bispecific-antibodies/72650186
2016-07-31-lakepharma-presentation-at-pegs-in-boston-2016-170228063551 Multi-domain Challenges of Fc Fusion Proteins and Bispecific Antibodies]]>
Multi-domain Challenges of Fc Fusion Proteins and Bispecific Antibodies]]>
Tue, 28 Feb 2017 06:35:51 GMT/slideshow/multidomain-challenges-of-fc-fusion-proteins-and-bispecific-antibodies/72650186JinDi2@slideshare.net(JinDi2)Multi-domain Challenges of Fc Fusion Proteins and Bispecific AntibodiesJinDi2Multi-domain Challenges of Fc Fusion Proteins and Bispecific Antibodies<img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/2016-07-31-lakepharma-presentation-at-pegs-in-boston-2016-170228063551-thumbnail.jpg?width=120&height=120&fit=bounds" /><br> Multi-domain Challenges of Fc Fusion Proteins and Bispecific Antibodies
]]>
12883https://cdn.slidesharecdn.com/ss_thumbnails/2016-07-31-lakepharma-presentation-at-pegs-in-boston-2016-170228063551-thumbnail.jpg?width=120&height=120&fit=boundspresentationBlackhttp://activitystrea.ms/schema/1.0/posthttp://activitystrea.ms/schema/1.0/posted0LakePharma鈥檚 CHO-GSN Platform for Stable Cell Line Generation
/slideshow/lakepharmas-chogsn-platform-for-stable-cell-line-generation/72650146
2016-08-23-lakepharma-presentation-at-cho-cell-line-development-conference-in-san-francisco-2016-170228063417 LakePharma鈥檚 CHO-GSN Platform for Stable Cell Line Generation]]>
LakePharma鈥檚 CHO-GSN Platform for Stable Cell Line Generation]]>
Tue, 28 Feb 2017 06:34:17 GMT/slideshow/lakepharmas-chogsn-platform-for-stable-cell-line-generation/72650146JinDi2@slideshare.net(JinDi2)LakePharma鈥檚 CHO-GSN Platform for Stable Cell Line GenerationJinDi2LakePharma鈥檚 CHO-GSN Platform for Stable Cell Line Generation<img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/2016-08-23-lakepharma-presentation-at-cho-cell-line-development-conference-in-san-francisco-2016-170228063417-thumbnail.jpg?width=120&height=120&fit=bounds" /><br> LakePharma鈥檚 CHO-GSN Platform for Stable Cell Line Generation
]]>
5574https://cdn.slidesharecdn.com/ss_thumbnails/2016-08-23-lakepharma-presentation-at-cho-cell-line-development-conference-in-san-francisco-2016-170228063417-thumbnail.jpg?width=120&height=120&fit=boundspresentationBlackhttp://activitystrea.ms/schema/1.0/posthttp://activitystrea.ms/schema/1.0/posted0LakePharma service brochure
/slideshow/lakepharma-service-brochure/72650036
2016-09-30-lakepharma-service-brochure-170228063030 lakePharma service brochure, CRO]]>
lakePharma service brochure, CRO]]>
Tue, 28 Feb 2017 06:30:30 GMT/slideshow/lakepharma-service-brochure/72650036JinDi2@slideshare.net(JinDi2)LakePharma service brochureJinDi2lakePharma service brochure, CRO<img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/2016-09-30-lakepharma-service-brochure-170228063030-thumbnail.jpg?width=120&height=120&fit=bounds" /><br> lakePharma service brochure, CRO
]]>
4075https://cdn.slidesharecdn.com/ss_thumbnails/2016-09-30-lakepharma-service-brochure-170228063030-thumbnail.jpg?width=120&height=120&fit=boundspresentationBlackhttp://activitystrea.ms/schema/1.0/posthttp://activitystrea.ms/schema/1.0/posted0https://cdn.slidesharecdn.com/profile-photo-JinDi2-48x48.jpg?cb=1532124707Jin Di is Ph.D. with 6+ years of Pharmaceutical / Biomedical research experience and knowledge of Technology Evaluation & Commercialization through Ideation (transform technology into products / services), Evaluation (assess potential opportunities) and Implementation (develop business plan). Professional, strategically thinking, flexible, self-motivated, and service-oriented.
Google Scholar Page: https://scholar.google.com/citations?hl=en&user=j0ipEOUAAAAJ
Summary of Qualifications:
6+ years of research experience in new biopharmaceutical formulation, pharmaceutical research equipped with profound knowledge in pharmacokinetics and biochemistry; In-depth Knowledge in drug delivery using...https://cdn.slidesharecdn.com/ss_thumbnails/2016-12-20-lakepharma-general-technical-overview-170228063918-thumbnail.jpg?width=320&height=320&fit=boundsslideshow/lakepharma-general-technical-overview/72650266LakePharma General Tec...https://cdn.slidesharecdn.com/ss_thumbnails/2016-10-24-protein-manufacturing-utilizing-a-titerless-baculovirus-platform-170228063744-thumbnail.jpg?width=320&height=320&fit=boundsslideshow/protein-manufacturing-utilizing-a-titerless-baculovirus-platform/72650228Protein Manufacturing ...https://cdn.slidesharecdn.com/ss_thumbnails/2016-07-31-lakepharma-presentation-at-pegs-in-boston-2016-170228063551-thumbnail.jpg?width=320&height=320&fit=boundsslideshow/multidomain-challenges-of-fc-fusion-proteins-and-bispecific-antibodies/72650186Multi-domain Challenge...